Nevro Corp
General ticker "NVRO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $157.0M
Nevro Corp does not follow the US Stock Market performance with the rate: -30.9%.
Estimated limits based on current volatility of 4.3%: low 3.65$, high 4.03$
Factors to consider:
- US accounted for 85.7% of revenue in the fiscal year ended 2022-12-31
- Current price 73.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [14.51$, 30.09$]
- 2024-12-30 to 2025-12-30 estimated range: [12.49$, 26.54$]
Financial Metrics affecting the NVRO estimates:
- Negative: Non-GAAP EPS, $ of -2.47 <= 0.10
- Negative: Operating profit margin, % of -18.93 <= 1.03
- Negative: Operating cash flow per share per price, % of -7.62 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.20
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term NVRO quotes
Long-term NVRO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $386.90MM | $406.37MM | $425.17MM |
| Operating Expenses | $497.84MM | $400.20MM | $524.48MM |
| Operating Income | $-110.93MM | $6.16MM | $-99.31MM |
| Non-Operating Income | $-19.89MM | $-1.90MM | $1.45MM |
| Interest Expense | $19.75MM | $6.43MM | $8.01MM |
| R&D Expense | $47.66MM | $53.06MM | $54.42MM |
| Income(Loss) | $-130.83MM | $4.26MM | $-97.86MM |
| Taxes | $0.53MM | $1.26MM | $-5.65MM |
| Profit(Loss) | $-131.36MM | $3.00MM | $-92.21MM |
| Stockholders Equity | $303.62MM | $323.88MM | $293.14MM |
| Inventory | $93.52MM | $99.64MM | $118.68MM |
| Assets | $574.54MM | $602.41MM | $635.71MM |
| Operating Cash Flow | $-41.88MM | $24.68MM | $-58.83MM |
| Capital expenditure | $12.34MM | $7.54MM | $8.59MM |
| Investing Cash Flow | $201.72MM | $64.29MM | $-7.20MM |
| Financing Cash Flow | $-169.38MM | $-2.46MM | $49.53MM |
| Earnings Per Share* | $-3.77 | $0.09 | $-2.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.